Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Base de datos
Tipo del documento
Asunto de la revista
Intervalo de año de publicación
1.
BMC Nephrol ; 25(1): 196, 2024 Jun 13.
Artículo en Inglés | MEDLINE | ID: mdl-38872134

RESUMEN

BACKGROUND: TAFRO syndrome is a rare disorder that causes thrombocytopenia, generalized oedema, fever, organ enlargement, and renal impairment. Few reports have suggested an association with vaccines, and few cases have undergone renal biopsy. TAFRO syndrome is often severe and fatal, and its cause is unknown. We report a case of TAFRO syndrome that occurred after vaccination with the coronavirus disease 2019 (COVID-19) vaccine. CASE PRESENTATION: An 82-year-old woman received two doses of the BNT162b2 mRNA vaccine 3 weeks apart. Two weeks later, she was admitted to the hospital with oedema, accompanied with renal failure and thrombocytopenia. After close examination, she was diagnosed with TAFRO syndrome. She was treated with steroids, cyclosporine, and thrombopoietin receptor agonists. The patient was discharged after several months in remission. CONCLUSIONS: Although an incident of TAFRO syndrome after COVID-19 vaccination has been previously reported, this is a rare case in which the patient went into remission and was discharged. A renal biopsy was also performed in this case, which was consistent with previous reports. The favorable treatment course for TAFRO syndrome provides valuable insights.


Asunto(s)
Ciclosporina , Humanos , Femenino , Ciclosporina/uso terapéutico , Ciclosporina/efectos adversos , Anciano de 80 o más Años , Trombocitopenia/inducido químicamente , Vacuna BNT162/efectos adversos , Inmunosupresores/uso terapéutico , Inmunosupresores/efectos adversos , Vacunas contra la COVID-19/efectos adversos , Edema/etiología , Edema/inducido químicamente , COVID-19/complicaciones , COVID-19/prevención & control
2.
Biochem Biophys Res Commun ; 696: 149500, 2024 Feb 12.
Artículo en Inglés | MEDLINE | ID: mdl-38219488

RESUMEN

Carbon ion radiotherapy (CIRT) is a heavy ion charge particle therapy with 29 years of prominent use. Despite advantages like high relative biological effectiveness (RBE), improved quality of life, and reduced treatment time, challenges persist, especially regarding heavy nuclear fragments. Our research addresses these challenges in horizontal irradiation, aiming to comprehend Monoenergetic and Spread-Out Bragg peak (SOBP) carbon ion beam trajectories using cell survival analysis and visualizing biological effects through DNA damage (γ-H2AX). This reveals repair-related protein foci near the Bragg peak. CR-39, a plastic nuclear track detector, was explored to understand high-linear energy transfer (LET) tracks and radiation quality near the Bragg peak. Findings unveil high-LET DNA damage signatures through aligned γ-H2AX foci, correlating with LET values in SOBP. CR-39 visualized high-LET particle exposure, indicating comet-type etch-pits at the Bragg peak and suggesting carbon ion fragmentation. Unexpectedly, dot-type etch-pits in irradiated and post-Bragg peak regions indicated high-LET neutron production. This investigation highlights the intricate interplay of carbon ion beams, stressing the importance of understanding LET variations, DNA damage patterns, and undesired secondary exposure.


Asunto(s)
Radioterapia de Iones Pesados , Transferencia Lineal de Energía , Polietilenglicoles , Calidad de Vida , Iones , Carbono , Daño del ADN , Muerte Celular
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA